Medfiles

Medfiles is an established contract research organization (CRO) with over 37 years of experience providing regulatory affairs, pharmacovigilance, and clinical study services for human and veterinary medicines as well as medical devices and food/feed products. The company recently sold its R&D and analytical laboratory division to Eurofins BioPharma Product Testing Finland in February 2025 to focus on its core business areas[5][1][2].

It serves clients ranging from early-stage startups to global pharmaceutical companies across Europe and globally. Its expertise covers the full product lifecycle from development through post-market activities[3][4].

The parent company of Medfiles is WDB Holdings (Tokyo Stock Exchange Prime Market)[5].

No proprietary drug pipeline or clinical results are associated with the company since it operates as a service provider.

Key partnerships include collaborations with LINK Medical for regulatory/pharmacovigilance services in Northern Europe[1] and past strategic partnerships such as with Clinipace Worldwide[8].